CXCL1, known for its chemotactic effect on neutrophils, is promoted by YHJD in liver tissues to induce the chemotaxis of anti-tumor neutrophil infiltration, potentially reducing liver metastasis in CRC patients. This evidence concerns the gene CXCL1 and neoplasm.